Table 3. Results by different subgroups.
| Author | Year | Criterion | Observation | Survival rate—UCSF | Survival rate—Milan | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| N | 1 year | 3 years | 5 years | N | 1 year | 3 years | 5 years | |||||
| Yao (18) | 2002 | Pathological | 60 | 0.900 | 0.820 | 0.750 | 46 | 0.910 | 0.810 | 0.720 | ||
| Leung (19) | 2004 | Radiological | 81 | 0.858 | 0.648 | 0.519 | 74 | 0.859 | 0.637 | 0.509 | ||
| Hwang (20) | 2005 | Pathological | 46 | – | 0.881 | – | 42 | – | 0.899 | – | ||
| Hwang (20) | 2005 | Pathological | Living donor | 167 | – | 0.906 | – | 151 | – | 0.914 | – | |
| Decaens (21) | 2006 | Pathological | 223 | – | – | 0.695 | 184 | – | – | 0,704 | ||
| Yang (22) | 2006 | Pathological | Living donor | 50 | – | 0.760 | – | 43 | – | 0.800 | – | |
| Yang (22) | 2006 | Radiological | Living donor | 41 | – | 0.780 | – | 37 | – | 0.800 | – | |
| Kwon (23) | 2007 | Pathological | Living donor | 89 | – | – | 0.800 | 84 | – | – | 0.800 | |
| Lo (24) | 2007 | Pathological | 51 | 0.980 | 0.880 | 0.720 | 44 | 0.980 | 0.890 | 0.710 | ||
| Parfitt (25) | 2007 | Pathological | 59 | – | 0.771 | 0.726 | 50 | – | 0.830 | 0.830 | ||
| Lee (26) | 2008 | Pathological | Living donor | 174 | 0.874 | 0.800 | 0.759 | 164 | 0.866 | 0.794 | 0.760 | |
| Toso (27) | 2008 | Pathological | 193 | – | – | 0.800 | 157 | – | – | 0.820 | ||
| Chen (28) | 2009 | Pathological | 132 | 0.864 | 0.796 | 0.767 | 117 | 0.872 | 0.803 | 0.771 | ||
| Chen (28) | 2009 | Radiological | 126 | 0.873 | 0.786 | 0.731 | 112 | 0.884 | 0.795 | 0.743 | ||
| Fan (29) | 2009 | Pathological | 489 | 0.862 | – | 0.792 | 394 | 0.866 | – | 0.788 | ||
| Muscari (30) | 2009 | Radiological | 75 | – | – | 0.780 | 73 | – | – | 0.790 | ||
| Vakili (31) | 2009 | Pathological | Living donor | 26 | – | – | 0.832 | 21 | – | – | 0.871 | |
| Wang (32) | 2009 | Pathological | 110 | 0.981 | 0.799 | – | 75 | 0.986 | 0.861 | – | ||
| Piardi (33) | 2011 | Pathological | 134 | 0.900 | 0.830 | 0.760 | 106 | 0.900 | 0.850 | 0.770 | ||
| Unek (34) | 2011 | Pathological | 41 | 0.903 | 0.819 | 0.819 | 34 | 0.912 | 0.877 | 0.877 | ||
| Choi (35) | 2013 | Pathological | Living donor | 150 | – | 0.822 | 0.813 | 130 | – | 0.808 | 0.798 | |
| Kaido (36) | 2013 | Radiological | Living donor | 127 | – | – | 0.770 | 118 | – | – | 0.760 | |
| Bonadio (37) | 2015 | Pathological | 43 | – | – | 0.740 | 39 | – | – | 0.740 | ||
| Xu (38) | 2015 | Radiological | 3,049 | 0.906 | 0.804 | 0.759 | 2,626 | 0.909 | 0.814 | 0.770 | ||
Final analysis of the different subgroups (donor type, population and tumor evaluation criteria did not show a significant difference and indicated the lack of possible selection biases).